Physician

Layne Marc Fielder, M.D.

According to 2025 Medicare claims, Layne Fielder, M.D. (NPI: 1740472380) practices dermatology in the Crestview-Fort Walton Beach-Destin, FL market, with the plurality of this provider's patient population coming from Okaloosa, FL. This provider's primary affiliated billing organization is COASTAL SKIN SURGERY AND DERMATOLOGY, PL (NPI: 1114238193; TIN: 272667115) and primary practice location at 32578-8779.

Fielder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,382 traditional Medicare patients, billed 11,143 HCPCS/CPT codes, and received $454,694 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 994 prescription claims across 345 beneficiaries totaling $218,369 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 53 records totaling $1,306. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $152,160 to $454,694. Similarly, Part D prescription costs have risen steadily, from $79,769 to $218,369. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$269K$539K2015 Medicare payment: $152,160 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $207,959 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $233,776 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $446,807 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $444,198 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $494,776 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $538,677 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $498,539 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $503,060 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $454,694 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156363,504$152,160
20168425,916$207,959
20179678,007$233,776
20181,71314,696$446,807
20191,84220,491$444,198
20201,83320,818$494,776
20211,73418,395$538,677
20221,63014,701$498,539
20231,48911,837$503,060
20241,38211,143$454,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$145K$290K2015 Drug cost: $79,769 (USD; Tot_Drug_Cst)2016 Drug cost: $56,171 (USD; Tot_Drug_Cst)2017 Drug cost: $108,542 (USD; Tot_Drug_Cst)2018 Drug cost: $51,858 (USD; Tot_Drug_Cst)2019 Drug cost: $41,059 (USD; Tot_Drug_Cst)2020 Drug cost: $129,983 (USD; Tot_Drug_Cst)2021 Drug cost: $187,687 (USD; Tot_Drug_Cst)2022 Drug cost: $290,099 (USD; Tot_Drug_Cst)2023 Drug cost: $265,573 (USD; Tot_Drug_Cst)2024 Drug cost: $218,369 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015124283$79,769
2016146412$56,171
2017192574$108,542
2018257785$51,858
2019269768$41,059
20203351,059$129,983
2021314862$187,687
2022277835$290,099
2023258777$265,573
2024345994$218,369

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth337386$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0791,470$64
17000Destruction of precancer skin growth, 1 growth8541,076$38
88305Pathology examination of tissue using a microscope, intermediate complexity319452$28
17003Destruction of precancer skin growth, 2-14 growths7083,936$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab29812$107,345
Clobetasol PropionateClobetasol Propionate1323,649$7,431
MetronidazoleMetronidazole411,154$2,012
KetoconazoleKetoconazole692,048$1,557
ValacyclovirValacyclovir Hcl321,829$1,427

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$1,306ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Layne Marc Fielder, M.D.?

Tedicare shows public-source Medicare data for Layne Marc Fielder, M.D. (NPI 1740472380), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Layne Marc Fielder, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Layne Marc Fielder, M.D.?

Layne Marc Fielder, M.D. is linked to COASTAL SKIN SURGERY AND DERMATOLOGY, PL (billing NPI 1114238193) in the available physician profile data.

Does Layne Marc Fielder, M.D. have Open Payments data?

Layne Marc Fielder, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.